#Oxurion #receives #transparency #notification #Fidelity
Leuven, BELGIUM, Boston, MA, USA – November 4th2022 – 7 pm CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard ophthalmic therapies with clinical-stage benefits in retinal vascular disease, today announced under Belgian transparency legislation1 it has received a transparency notification following the issuance of new shares in accordance with the capital commitment made with Negma Group.
Oxurion has received a transparency notice from Fidelity Management & Research Company LLC stating that its 3,128,819 common shares have fallen below the 5% threshold due to a passive breach of a threshold.
Content of the loyalty message
reason for notification
Passive crossing of a threshold
notifications from
A parent company or controlling person
threshold that is exceeded
5%
denominator
66,675,765
Notified details
See Appendix 1
Chain of companies controlled by …
Read on GNW: Oxurion receives transparency notification from Fidelity
